Currently, there are 74.39M common shares owned by the public and among those 71.22M shares have been available to trade.
The company’s stock has a 5-day price change of -10.22% and -1.95% over the past three months. MDB shares are trading -28.85% year to date (YTD), with the 12-month market performance down to -23.81% lower. It has a 12-month low price of $212.74 and touched a high of $509.62 over the same period. MDB has an average intraday trading volume of 1.35 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -7.65%, 0.23%, and -2.88% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of MongoDB Inc (NASDAQ: MDB) shares accounts for 91.35% of the company’s 74.39M shares outstanding.
It has a market capitalization of $21.49B and a beta (3y monthly) value of 1.18. The earnings-per-share (ttm) stands at -$2.74. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.83% over the week and 4.85% over the month.
Earnings per share for the fiscal year are expected to decrease by -11.03%, and 12.21% over the next financial year. EPS should grow at an annualized rate of 14.20% over the next five years, compared to -5.43% over the past 5-year period.
Loop Capital coverage for the MongoDB Inc (MDB) stock in a research note released on April 23, 2024 offered a Buy rating with a price target of $415. Redburn Atlantic was of a view on March 19, 2024 that the stock is Sell, while DA Davidson gave the stock Buy rating on March 08, 2024, issuing a price target of $405- $430. UBS on their part issued Neutral rating on January 04, 2024.
